BRIMONIDINE TARTRATE AND TIMOLOL MALEATE

Generic: BRIMONIDINE TARTRATE AND TIMOLOL MALEATE

Upsher-Smith LaboratoriesManufacturer
OPHTHALMICRoute
BRIMONIDINE TARTRATEActive Substance
2022-12-12Original Approval

BRIMONIDINE TARTRATE AND TIMOLOL MALEATE is FDA application ANDA215598, sponsored by UPSHER SMITH LABS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
BLINDNESS
4 reports
2
EYE DISORDER
4 reports
3
BLINDNESS UNILATERAL
3 reports
4
OCULAR HYPERAEMIA
3 reports
5
DEATH
2 reports
6
DRY EYE
2 reports
7
EYE PAIN
2 reports
8
GLAUCOMA
2 reports
9
OPTIC NERVE INJURY
2 reports
10
PRODUCT SUBSTITUTION ISSUE
2 reports